Back to Search
Start Over
Sanofi says moderate-to-severe atopic hand, foot dermatitis trial met endpoints
- Source :
- The Fly. March 18, 2023
- Publication Year :
- 2023
-
Abstract
- Sanofi reported 'positive' results from the clinical trial assessing Dupixent in adults and adolescents with uncontrolled moderate-to-severe atopic hand and foot dermatitis were presented today. The trial, which the company [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.741861842